All News
RheumNow Podcast – ACR 2020 Epilogue (11.20.20)
Dr. Jack Cush reviews a few more ACR 2020 abstracts and presents a new plan to learn or take in ACR20 content.
Read Article
Flu and Tofacitinib
Dr. Kathryn Dao reviews abstract L04 - Influenza Adverse Events in Patients with Rheumatoid Arthritis in the Tofacitinib Clinical Program - at the 2020 ACR annual meeting.
Read Article
The folly of dietary restriction in contemporary gout?
Gout has historically been considered a disease of the financially rich, rich in diet, and rich in alcohol.
Read Article
Watch our #ACR20 video recap titled "Treatment of Dermatomyositis Studies" with Dr Robert Chao (@doctorRBC). Dr. Chao reviews two important abstracts - #0955 and #0958 - on the treatment of dermatomyositis as presented at the 2020 ACR annual meeting.
https://t.co/1hiTZQVjlL https://t.co/CW9OGHTuJg
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACRTweets20
RT @RHEUMarampa : IgG4-RD tx: GCs are mainstay tx starting at 30-40mg/d tapered gradually but 30% of pts will have recurrences
Potential therapeutic targets to ⬇GC toxicity
✏B cell/plasmablasts (promising)
✏T cells (anecdotal) #ACR20 https://t.co/htu849kng3
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @synovialjoints : New mode of action treatment in AS. The SELECT-AXIS 1 showed Upadacitinib 15mg od showed sustained efficacy over 1 year @RheumNow #ACR20 Abstr#2023 #ACRbest https://t.co/Auo3AMNTDw
Links:
Dr. John Cush RheumNow ( View Tweet)
What is the SEAMless transition from combination Etanercept to Methotrexate? Dr. Jonathan Kay takes a deep dive into plenary abstract #0939 presented at #ACR20 annual meeting, reviewing two previous clinical trials that also looked at this question.
https://t.co/58raeaE8Mr https://t.co/ZP2P0IZ1Fc
Links:
Dr. John Cush RheumNow ( View Tweet)
View one of our fantastic #ACR20 video titled "Staying on Therapy in RA" with Dr. Janet Pope ( @Janetbirdope)
https://t.co/imCpxVs2N8 https://t.co/AcTBGaapig
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestARC20Tweets
"RT @drdavidliew : Great to sit down with @LCalabreseDO @Sarah_L_Mackie @RichardPAConway a few hours ago and chat about two very interesting GCA therapeutics abstracts: https://t.co/V3fzB0W3Ko
great discussion!
#ACR20 @RheumNow"
Links:
Dr. John Cush RheumNow ( View Tweet)
Read our article titled: Best Imaging Techniques for non ANCA Vasculitis by Dr. Alexa Meara ( @lexmeara) as discussed at #ACR20 https://t.co/CyfC8bdq42 https://t.co/Ay7Sw0eMTY
Links:
Dr. John Cush RheumNow ( View Tweet)
What was your favorite abstract or study presented at #ACR20? We've rounded up our top choices. #ACRbest https://t.co/50hpUUSCBD https://t.co/09t2kziLQr
Links:
Dr. John Cush RheumNow ( View Tweet)
What is the SEAMless transition from combination Etanercept to Methotrexate? with Dr. Jonathan Kay #ACR20
https://t.co/58raeaE8Mr https://t.co/FUIidcoy4I
Links:
Dr. John Cush RheumNow ( View Tweet)
The #ACR20 convergence highlighted a shift in gout management and uric acid lowering therapy (ULT). Read more about mitigating immunogenicity when using uricase therapies as ULT in an article by Dr. Alexa Meara ( @lexmeara) https://t.co/5AfyFhJGqp https://t.co/Sv1BiI0Uwd
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out our article titled: FAST, FREED, CARES, & CONFIRMS: A Run-Down on the Black-Box Blues of Febuxostat by Dr. Meral K. El Ramahi ( @MeralElRamahiMD). #ACR20
https://t.co/dKhotXONGP https://t.co/KfsFFX7z0D
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out our video on representation of women authors in rheumatology: Dr Bella Mehta ( @bella_mehta) #ACR20
https://t.co/4EAiiSwye8 https://t.co/AS1P8IseJT
Links:
Dr. John Cush RheumNow ( View Tweet)
Improving Drug Adherence in RA: Dr Janet Pope ( @Janetbirdope) Reviews abstract #799 presented at #ACR20.
https://t.co/ONCJmCOdzC https://t.co/ornpQiopTS
Links:
Dr. John Cush RheumNow ( View Tweet)
Great read! "The Vaccine Review Process and Why You Should Know It" by Dr. Rachel Tate ( @uptoTate)
https://t.co/l39qH3LuXm https://t.co/PR1AaQCD7V
Links:
Dr. John Cush RheumNow ( View Tweet)
SEAM-RA Trial: Dr. Jeff Curtis ( @RADoctor) discusses abstract # 0939 that looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at #ACR20
https://t.co/2yMyj4BKs1 https://t.co/2gqJM4EKpG
Links:
Dr. John Cush RheumNow ( View Tweet)
Long-Term Benefits of Ixekizumab in Psoriatic Arthritis
https://t.co/CaGVSvFzVd https://t.co/ktdG5nt96f
Links:
Dr. John Cush RheumNow ( View Tweet)
PsA Studies: Entheses, Ultrasound, Swollen not Tender Joints: Dr. Antoni Chan ( @synovialjoints) #ACR20
https://t.co/S6Nj9eWnTF https://t.co/qDOT2TwfHl
Links:
Dr. John Cush RheumNow ( View Tweet)